|
J Biol Chem, Vol. 275, Issue 18, 13179-13182, May 5, 2000
ACCELERATED PUBLICATION
A Novel Lipopolysaccharide Response Element in the Bombyx
mori Cecropin B Promoter*
Kiyoko
Taniai § and
Shuichiro
Tomita¶
From the Laboratory of Biological Defense, Department
of Insect Physiology and Behavior and the ¶ Department of Insect
Genetics and Breeding, National Institute of Sericultural and
Entomological Science, Tsukuba 305-8634, Japan
 |
ABSTRACT |
Cecropin B is one of the major antibacterial
peptides in the silkworm, Bombyx mori. Transcription of the
cecropin B gene (CecB) occurs rapidly after bacterial
invasion. Using 235 base pairs (bp) of the CecB promoter
region, a B-related protein and two additional DNA-binding complexes
(designated F2BPI and F4BP) were identified in nuclear extracts from
immunized larval fat body by the electrophoretic mobility shift assay
(EMSA) (1). Further EMSA analyses indicated that the F2BPI-binding site
was CATTA, and that F2BPI translocated from the cytoplasm to the
nucleus after infection. In a recently established B. mori
cell line, NISES-BoMo-DZ, 235 bp of CecB promoter linked to
a reporter luciferase was activated 6-fold by stimulation with
lipopolysaccharide (LPS), which is a major trigger of CecB
expression in larvae. Truncation of the F2BPI-binding site from the
promoter reduced the activation 2-fold. Deletion of either of two B
motifs also reduced promoter activation 2-fold. Elimination of both the
F2BPI-binding site and the B motifs resulted in the complete loss of
LPS inducibility. These results indicate that the F2BPI-binding site is
an LPS-responsive cis-element that is necessary for full
activation of CecB.
 |
INTRODUCTION |
Insects have developed an effective innate immune system
consisting of humoral and cellular responses. Rapid induction of several antimicrobial peptides in the hemolymph is a major humoral defense against microorganisms (2, 3). Five different peptides have
been isolated from the hemolymph of Bombyx mori larvae
immunized by bacterial injection: cecropin A, cecropin B, cecropin D,
lebocin, and moricin (4, 5). The expression of these genes occurs simultaneously in fat body cells and hemocytes within a few hours of
bacterial injection (6, 7). Triggers activating the antibacterial cecropin B gene (CecB)1 have been characterized
in detail (6). Various species of LPS,
Lipid A (the lipid part of the LPS core), 2-keto-3-deoxyoctonate (a
saccharide in the LPS core), peptidoglycan (PG), and lipoteicoic acid
(LTA) from bacteria induced the gene expression strongly. However,
laminarin, zymozan, and scyzophillan, all of which contain mainly
-1,3-glucan, or spores of Beauveria bassiana never
induced any gene expression. -1,3-glucan is a common cell wall
component of fungi. These observations indicate that B. mori
distinguishes bacteria from fungi and expresses CecB in a
bacteria-specific response.
The structure of CecB has been analyzed to elucidate the
bacteria-specific gene activation mechanism (1). At least four copies
of the genes exist in each individual. Two cloned genes, CecB1 and CecB2, revealed 90% identity with the
upstream region spanning 800 bp, suggesting that the genes are
regulated by the same transcription factors. In the proximal region of
the promoters, two B-like decamer motifs, three GATA, sites and one
mammalian type II interleukin-6 response element (IL-6RE) were found.
The electrophoretic mobility shift assay (EMSA) identified three
different DNA-binding proteins that bind to 235 bp of the
CecB1 promoter. One of the proteins is probably a
B-related factor because competition with a B-like sequence
inhibited the binding (1). We designated the other proteins F2BPI and F4BP.
B motifs and a GATA site have been identified in most insect
immune-inducible protein genes (8, 9). The induction mechanisms of
antimicrobial peptide gene expression have been well studied in
Drosophila melanogaster. NF- B-related factors of the Rel
family (Dorsal, Dif, and Relish) (10-12) and a GATA site-binding
protein (Serpent) (13) play major roles in the induction. Several other mammalian cis-elements have been reported in insect
immune-inducible promoters, such as both type I and type II IL-6REs and
the interferon response element (14, 15). The presence of the nuclear
factors for these elements was suggested in the D. melanogaster diptericin promoter using the DNase I footprinting
assay (16). However, the function of the elements has not been verified.
In this study, we characterized one of the DNA-binding proteins, F2BPI.
We found that the F2BPI-binding site consists of two CATTA in the
CecB promoter region. Furthermore, we explored a B. mori cell line that responds to bacterial cell wall components. Transfection assays using these cells revealed that the F2BPI-binding site is necessary for full activation of the CecB1 promoter
by LPS.
 |
EXPERIMENTAL PROCEDURES |
Insects, Nuclear and Cytoplasmic Extracts, and
EMSA--
B. mori larvae (Tokai × Asahi strain) were
reared on an artificial diet (Nohon Nosanko) at 26 °C and were used
at day 3 of the fifth instar. The fat bodies were dissected from
control larvae, or from larvae injected with autoclaved
Escherichia coli (107 cells/larva), and
incubated at 26 °C for 4, 6, or 12 h. A nuclear extract was
prepared by the method of Kobayashi et al. (17), and a
cytoplasmic extract was prepared as described (18). EMSA using
32P-labeled F2 or F2S DNA (8 fmol) and competitor (800 fmol) was done by essentially the same method as described previously
(1).
Oligonucleotide Probes and Competitors--
Oligonucleotides
were synthesized in a DNA synthesizer (model 392, Applied
Biosystems). F2 DNA probe was prepared by annealing of two
oligonucleotides, 5'-AATCCTCATTAACTGGGAGAGCATTAATTGAGGGGATTAACTTTTA-3' and 5'-TAAAAGTTAATCCCCTC-3', and then the gap was filled using Klenow
fragment in the presence of [ -32P]dATP, dCTP, dGTP,
and dTTP. F2S DNA probe was prepared by annealing two oligonucleotides,
5'-TCATTAACTGGGAGAGC-3' and 5'-TAATGCTCTCCCAGT-3', and then the
gap was filled by the same method described above. Four competitors
were prepared by annealing two complementary oligonucleotides. The
sequences of the upper strands of the competitors are shown in Fig.
1A.
Cell Lines and Triggers--
B. mori BmN4 and
NISES-BoMo-DZ (19) and Spodoptera frugiperda Sf9 were
provided by Dr. Shigeo Imanishi, Department of Insect Genetics and
Breeding, of our institute. D. melanogaster Schneider line 2 (SL2) cells were a gift from Dr. Kumiko Tei, Nippon Medical School.
These cells were maintained at 26 °C. The culture medium was EX-CELL
(JRH Biosciences) for BmN4, SF900II (Life Technologies, Inc.) for
NISES-BoMo-DZ and Sf9, and Shields and Sang M3 (Sigma) for SL2
cells. All media were supplemented with 5-10% fetal bovine serum
(TRACE Scientific Ltd.), 100 units/ml of penicillin, and 0.1 mg/ml of
streptomycin. LPS from E. coli 0111:B4 was purchased from
DIFCO. Laminarin from Laminaria digitata and LTA from
Staphylococcus aureus were from Sigma. PG from
Micrococcus luteus was obtained from Wako Pure Chemical.
Reporter Assay--
All reporter plasmids were constructed using
pGL3-Basic vector (Promega). A minimum promoter region ( 79 to +10)
from the B. mori actin A3 gene (20) was fused with the
CecB1 promoter region and then inserted upstream from the
luciferase gene in the vector. Various lengths of CecB1
promoter regions (790, 479, 235, 200, 151, and 123 bp), which were from
immediately upstream of the TATA box to further upstream, were
amplified by polymerase chain reaction using
pBlueScript-CecB1 (1) as a template. The resulting plasmids
were pC790, pC479, pC235, pC200, pC200, pC151, and pC123, respectively.
Deletion mutant plasmids (pD 1, pD 2, pDG1, and pDG2) were created
using a GeneEditor in vitro site-directed mutagenesis system
(Promega) using pC235 as a template. To remove a 72-bp region
(pDF G), two 6-bp sequences in pC235 were mutated to
SalI sites, and the plasmid was then digested with
SalI followed by ligation. The nucleotide sequences of the
mutants are shown in Fig. 3. One day before transfection, the cells
were seeded at 3 × 105/well in 24-well plates
(Falcon) and transfected with 500 ng of the plasmid/well mediated by a
cationic ion lipid, Tfx10 (Promega). To measure the relative
transfection efficacy, the plasmid, pA3-LacZ (a gift from Dr. Pierre
Couble) (20), which encodes LacZ under the A3 promoter was
co-transfected at 500 ng/well. The transfected cells were either
incubated with 100 µg/ml of LPS (final concentration) or left without
LPS for 24 h before the luciferase activity was measured using a
luciferase assay system (Promega) and Lumicounter-700 (Microtec Co.,
Ltd., Funabashi, Japan). The relative -gal activity was measured
using a chemiluminescent assay system, Galacto-Light Plus (TROPIX, Inc).
 |
RESULTS |
Determination of the Binding Sequence of F2BP--
Two nuclear
proteins with differing migration patterns were bound to the F2 DNA
fragment in EMSA (Fig. 1A,
lane 2). F2 contains a B-like motif, GGGATTAACT, and an
IL-6RE, CTGGGA. The fast migrating band is probably the B-like
protein described previously. We designated the slow migrating complex
F2BPI (F2-binding protein I). To
determine the F2BPI binding sequence, we used four different competitors in EMSA. Competitor F2S, which is a partial sequence of F2
(Fig. 1A, lane 4), inhibited F2BPI binding.
Competitor M1, which has two point mutations in IL-6RE, also inhibited
F2BPI binding (Fig. 1A, lane 5). Thus, the
binding site of F2BPI is not identical to IL-6RE. In competitor M2, two
CATTA were replaced by GCCGG and CAACG, respectively. As shown in
lane 6, M2 could not inhibit the formation of the F2BPI
complex. Therefore, CATTA is an important sequence for F2BPI binding.
The C oligo, which contains a B-like motif from the
CecB promoter region, did not inhibit F2BPI binding, but it
inhibited the formation of the fast migrating complex (Fig.
1A, lane 7).

View larger version (62K):
[in this window]
[in a new window]
|
Fig. 1.
Determination of binding site and cellular
localization of F2BPI. A, EMSA competition assay. A
32P-labeled F2 probe was mixed without (lane 1)
and with nuclear extracts from immunized larval fat bodies (lanes
2-7). The upper strand of the competitors is depicted
below the EMSA photograph. Bold letters indicate
IL-6RE, italics indicate the B-like motifs, and the
probable F2BPI-binding sites are underlined. B,
F2BPI localizes to the cytoplasm of the fat body. EMSAs were done using
the F2S probe and nuclear (N12) and cytoplasmic
(C12) extracts from larval fat body of 12-h immunization.
The specific competitor was mixed at the indicated excess level.
C, localization and time course of F2BPI. EMSAs were done
using the F2S probe and nuclear (N0, N4, N6, and
N12) or cytoplasmic (C0 and C12)
extracts. The numbers after N and C
indicate hours after immunization.
|
|
Cellular Localization of F2BPI--
The cellular localization of
F2BPI was analyzed by EMSA. Using F2S probe, one distinct band shift
was observed in both nuclear and cytoplasmic extracts from 12-h
immunized larvae (Fig. 1B). This band was inhibited by a
specific competitor, F2S. In the cytoplasmic extract, another faint
band was observed at a higher position than F2BPI, and F2S also
inhibited this band. Similarly, two bands were observed in normal
cytoplasmic extract (Fig. 1C, C0). No band shift was
observed in normal nuclear extract (Fig. 1C, N0). The
intensity of F2BPI was similar in nuclear extracts from 4 and 6 h,
but it declined slightly at 12 h. These results indicate that
F2BPI is localized in the cytoplasm and then translocates to the
nucleus upon infection.
NISES-BoMo-DZ Respond to Various CecB Triggers--
No other
B. mori cell line that responds to bacterial challenge has
been reported. To develop a promoter assay system of immune-related genes using culture cells, we screened four cell lines,
NISES-BoMo-DZ, BmN4, Sf9, and SL2 cells. To test the
cell lines, a reporter plasmid (pC235) carrying luciferase under the
control of 235 bp of the CecB1 promoter was transfected and
analyzed with and without LPS stimulation. After incubation with LPS,
luciferase activity increased 6-fold in NISES-BoMo-DZ and 2-fold in
Sf9 cells (Fig. 2A).
The luciferase activities in BmN4 and SL2 cells were not changed after LPS addition. The induced activity of the CecB1 promoter in
NISES-BoMo-DZ increased in an LPS dose-dependent manner
(Fig. 2B). The other triggers for CecB expression
in larvae, PG, and LTA also increased luciferase activity in a
dose-dependent manner (Fig. 2B). On the other
hand, the cells did not respond to laminarin, in which -1,3-glucan is a major component (Fig. 2B). As laminarin cannot induce
CecB expression in larvae, the response of NISES-BoMo-DZ is
similar to that of larvae. The responses suggest that this cell line
can be used as a model system to analyze gene regulation of
antibacterial peptides in B. mori.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 2.
Activation of the CecB1
promoter with bacterial cell wall components in NISES-BoMo-DZ
cells. A, transient expression of luciferase under control of 235 bp of the CecB1 promoter in four insect cell lines. 24 h after transfection with pC235, cells were incubated with (black
bars) or without (white bars) LPS. After 24 h,
luciferase activity was measured. Luciferase activity in each sample
was corrected by the -gal activity generated from the control
plasmid, pA3-LacZ. All assays were done in triplicate. B,
NISES-BoMo-DZ cells were transfected with pC235 and incubated with
various concentrations of LPS, PG, LTA, or laminarin for 24 h.
Luciferase activity was measured, and each value was corrected by
control -gal activity. T-bars indicate the S.D. using
data from at least three independent experiments.
|
|
F2BPI-Binding Site Is Necessary for Full Activation of CecB1
Promoter--
To examine the functions of the F2BPI site, B motifs,
and GATA sites in the activation of the CecB1 promoter, we
transfected NISES-BoMo-DZ cells with the reporter plasmids containing
different lengths of wild-type and mutated CecB1 promoters
(Fig. 3). As shown in Fig.
4, the luciferase activity generated by
pC790, pC479, pC235, pC200, pC151, pDG1, and pDG2 (all of these
plasmids contain the F2BPI site, B motifs, and two GATA sites) did
not differ significantly. Induction of luciferase activity by LPS was
raised 4-6-fold. The induction with pC123 lacking the F2BPI site was increased only 2-fold. Deletion of either of the B motifs also decreased the level of induced activity. The induction with pD 1 and
pD 2 was 2-fold. Deletion of both B motifs further reduced the
induction level to 1.8-fold. Elimination of both the F2BPI site and the
B motifs (pDF G) resulted in the complete loss of LPS
inducibility of the promoter. Most of the plasmids except pD 1,
pD G, and pDF G produced basal activity that was about 10-fold the activity of the control vector without CecB1
promoter.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 3.
Nucleotide sequences of the mutant
CecB1 promoters. The promoter sequence around
possible cis-elements and the 5'-end of the promoter in
pC150 and pC123 are depicted. The B-like 1 motif can be oriented in
either direction. Dashes indicate the deletion of a
nucleotide.
|
|

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 4.
Both the F2BPI-binding site and the
B-like motifs are required for LPS-inducible
CecB1 promoter activity. Schematic structures of
the transfected plasmids are shown on the left. Transient
expression levels of luciferase activity under the control of different
lengths of wild-type or deletion mutant promoters of CecB1
are represented by white (basal activity) and
gray (induced activity) bars. T-bars
indicate the S.D. of at least three independent experiments. Each value
was corrected by -gal activity with co-transfected pA3-LacZ.
|
|
 |
DISCUSSION |
We identified NISES-BoMo-DZ as a useful cell line for assaying
promoter activity of immune-inducible genes. We tested whether endogenous CecB is expressed in the cells by Northern blot
analysis and found that the cells were incapable of expressing
CecB with or without LPS (data not shown). Nevertheless,
this cell line recognizes bacterial cell wall components and possesses
the cellular signaling pathway(s) to activate exogenous CecB
promoter constructs. Using this cell line, the F2BPI site was
identified as a cis-element necessary for the full response
to LPS (compare pC151 with pC123, Fig. 4). In addition, both B
motifs are functional and required for full activation of the
CecB promoter. The plasmid (pD G) without B motifs
still has LPS inducibility, suggesting that the F2BPI site is capable
of inducing the CecB promoter independently of the B
motifs. F2BPI and the B motifs seem to contribute equally to LPS
inducibility. The basal activities of the promoters with the F2BPI site
and the B motifs suggest that NISES-BoMo-DZ cells are constitutively
stimulated in medium without the addition of bacterial factors. No
other site spanning 790 bp of the promoter region was identified as
important for LPS inducibility. In our system, deletion of any one GATA
site did not affect promoter activity at all.
We determined that the probable F2BPI site consists of two CATTA,
although we did not identify the binding sequence precisely. Further
experiments should determine whether both CATTA are required or whether
one is enough for CecB1 promoter activation. The CATTA appears as a mammalian immune-related cis-element in CLEO,
the conserved lymphokine element
0, and in the promoter of IL-4, IL-5, and human
granulocyte/macrophage colony-stimulating factor (GM-CSF) (21, 22). The
function of the CATTA has been demonstrated using the GM-CSF promoter
(23). In this case, CATTT was also functional. The CATT(A/T) repeat in
the promoter was required for gene expression in T-lymphocytes and
several leukemia cells. Because GM-CSF gene expression is induced by
LPS in macrophages (24), CATT(A/T) also could be an LPS response
element of this gene. If so, CATT(A/T) is a common LPS response
cis-element in mammals and insects, in addition to the B
motifs and GATA site.
We examined the 5' upstream region of other LPS-inducible genes for the
presence of the CATT(A/T) motif and found that most insect
immune-inducible genes contain this motif. In B. mori, two
CATTA are conserved in CecB1 and CecB2, and one
is conserved in CecA1 and CecA2. Other B. mori genes and other genes from four different insect species
contain one to seven copies of CATT(A/T) on both or either strand in
the proximal promoter region, although the number and position vary
(Table I). The wide distribution of
CATT(A/T) suggests that this sequence is a common LPS response element
in insect immune-inducible genes.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Ylva Engström for
critical reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported by the project "Development of
Effective Animal Genome Analysis Techniques and the Application of Useful Genes" of the Ministry of Agriculture, Forestries and
Fisheries, Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Laboratory of
Biological Defense, Dept. of Insect Physiology and Behavior, National Institute of Sericultural and Entomological Science, Tsukuba 305-8634, Japan. Tel.: 81-298-38-6154; Fax: 81-298-38-6028; E-mail: taniai@ nises.affrc.go.jp.
 |
ABBREVIATIONS |
The abbreviations used are:
CecB, cecropin B gene;
LPS, lipopolysaccharide;
EMSA, electrophoresis
mobility shift assay;
PG, peptidoglycan;
LTA, lipoteichoic acid;
IL, interleukin;
IL-6RE, IL-6 response element;
SL2, Schuneider line 2;
GM-CSF, granulocyte/macrophage colony-stimulating factor;
bp, base pair(s);
-gal, -galactosidase;
F2BPI, F2-binding protein
I.
 |
REFERENCES |
| 1.
|
Taniai, K.,
Kadono-Okuda, K.,
Kato, Y.,
Yamamoto, M.,
Shimabukuro, M.,
Chowdhury, S.,
Xu, J.,
Kotani, E.,
Tomino, S.,
and Yamakawa, M.
(1995)
Gene
163,
215-219[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Boman, H. G.
(1995)
Annu. Rev. Immunol.
13,
61-92[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Natori, S.
(1994)
in
Antimicrobial Peptides
(Boman, H. G., ed)
, pp. 123-134, John Wiley & Sons, Chichester, UK
|
| 4.
|
Teshima, T.,
Nakai, T.,
Ueki, Y.,
and Shiba, T.
(1987)
Tetrahedron
43,
4513-4518[CrossRef]
|
| 5.
|
Yamakawa, M.,
and Tanaka, H.
(1999)
Dev. Comp. Immunol.
23,
281-289[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Taniai, K.,
Furukawa, S.,
Shono, T.,
and Yamakawa, M.
(1996)
Biochem. Biophys. Res. Commun.
226,
783-790[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Furukawa, S.,
Tanaka, H.,
Nakazawa, H.,
Ishibashi, J.,
Shono, T.,
and Yamakawa, M.
(1999)
Biochem. J.
340,
265-271
|
| 8.
|
Hultmark, D.
(1993)
Trends Genet.
9,
178-183[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Engström, Y.
(1997)
in
Molecular Mechanisms of Immune Responses in Insects
(Brey, P. T.
, and Hultmark, D., eds)
, pp. 213-244, Chapman & Hall, London
|
| 10.
|
Petersen, U.-M.,
Bjorklund, G.,
Ip, Y. T.,
and Engström, Y.
(1995)
EMBO J.
14,
3146-3158[Medline]
[Order article via Infotrieve]
|
| 11.
|
Gross, I.,
Georgel, P.,
Kappler, C.,
Reichhart, J.-M.,
and Hoffmann, J. A.
(1996)
Nucleic Acids Res.
24,
1238-1245[Abstract/Free Full Text]
|
| 12.
|
Dushay, M. S.,
Åsling, B.,
and Hultmark, D.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10343-10347[Abstract/Free Full Text]
|
| 13.
|
Petersen, U.-M.,
Kadalayil, L.,
Rehorn, K.-P.,
Hoshizaki, D. K.,
Reuter, R.,
and Engström, Y.
(1999)
EMBO J.
18,
4013-4022[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Reichhart, J.-M.,
Meister, M.,
Dimarcq, J.-L.,
Zachary, D.,
Hoffmann, D.,
Ruiz, C.,
Richards, G.,
and Hoffmann, J. A.
(1992)
EMBO J.
11,
1469-1477[Medline]
[Order article via Infotrieve]
|
| 15.
|
Yanano, Y.,
Matsumoto, M.,
Sasahara, K.,
Sakamoto, E.,
and Morishima, I.
(1998)
Biosci. Biotechnol. Biochem.
62,
237-241[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Georgel, P.,
Meister, M.,
Kappler, C.,
Lemaitre, B.,
Reichhart, J.-M.,
and Hoffmann, J. A.
(1993)
Biochem. Biophys. Res. Commun.
197,
508-517[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Kobayashi, A.,
Matsui, M.,
Kubo, T.,
and Natori, S.
(1993)
Mol. Cell. Biol.
13,
4049-4056[Abstract/Free Full Text]
|
| 18.
|
Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K.
(eds)
(1995)
Current Protocols in Molecular Biology, Ch. 12.1
, Greene Publishing Associates/Wiley-Interscience, New York
|
| 19.
|
Imanishi, S.,
Cho, E.-S.,
and Tomita, S.
(1999)
Appl. Entomol. Zool.
34,
259-266
|
| 20.
|
Mange, A.,
Julien, E.,
Prudhomme, J.-C.,
and Couble, P.
(1997)
J. Mol. Biol.
265,
266-274[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Miyatake, S.,
Shlomai, J.,
Arai, K.,
and Arai, N.
(1991)
Mol. Cell. Biol.
11,
5894-5901[Abstract/Free Full Text]
|
| 22.
|
Thomas, M. A.,
Mordvinov, V. A.,
and Sanderson, C. J.
(1999)
Eur. J. Biochem.
265,
300-307[Medline]
[Order article via Infotrieve]
|
| 23.
|
Nimer, S.,
Fraser, J.,
Richards, J.,
Lynch, M.,
and Gasson, J.
(1990)
Mol. Cell. Biol.
10,
6084-6088[Abstract/Free Full Text]
|
| 24.
|
Rao, P.,
Falk, L. A.,
Dougherty, S. F.,
Sawada, T.,
and Pluznik, D. H.
(1997)
J. Immunol.
159,
3531-3539[Abstract]
|
| 25.
|
Taniai, K.,
Ishii, T.,
Suguyama, M.,
Miyanoshita, M.,
and Yamakawa, M.
(1996)
Biochem. Biophys. Res. Coomun.
220,
594-599[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Furukawa, S.,
Taniai, K.,
Ishibashi, J.,
Hara, S.,
Shono, T.,
and Yamakawa, M.
(1997)
Biochem. Biophys. Res. Commun.
238,
769-774[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Kanai, A.,
and Natori, S.
(1990)
Mol. Cell. Biol.
10,
6114-6122[Abstract/Free Full Text]
|
| 28.
|
Kotani, E.
(1995)
Structure and Function of Hemocytin, a Bombyx mori Humoral Lectin, Which Is Homologous with the Mammalian von Willebrand Factor. Doctoral dissertation
, Kyoto Institute of Technology
|
| 29.
|
Ochiai, M.,
and Ashida, M.
(1999)
J. Biol. Chem.
274,
11854-11858[Abstract/Free Full Text]
|
| 30.
|
Gudmundsson, G. H.,
Lidholm, D.-A.,
Asling, B.,
Gan, R.,
and Boman, H. G.
(1991)
J. Biol. Chem.
266,
11510-11517[Abstract/Free Full Text]
|
| 31.
|
Xanthopoulos, K. G.,
Lee, J.-Y.,
Gan, R.,
Kockum, K.,
Faye, I.,
and Boman, H. G.
(1988)
Eur. J. Biochem.
172,
371-376[Medline]
[Order article via Infotrieve]
|
| 32.
|
Sun, S.-C.,
Asling, B.,
and Faye, I.
(1991)
J. Biol. Chem.
266,
6644-6649[Abstract/Free Full Text]
|
| 33.
|
Sun, S.-C.,
Lindstrom, I.,
Lee, J.-Y.,
and Faye, I.
(1991)
Eur. J. Biochem.
196,
247-254[Medline]
[Order article via Infotrieve]
|
| 34.
|
Lindstrom-Dinnetz, I.,
Sun, S. C.,
and Faye, I.
(1995)
Eur. J. Biochem.
230,
920-925[Medline]
[Order article via Infotrieve]
|
| 35.
|
Wang, Y.,
Willott, E.,
and Kanost, M. R.
(1995)
Insect Mol. Biol.
4,
113-123[Medline]
[Order article via Infotrieve]
|
| 36.
|
Kylsten, P.,
Samakovlis, C.,
and Hultmark, D.
(1990)
EMBO J.
9,
217-224[Medline]
[Order article via Infotrieve]
|
| 37.
|
Tryselius, Y.,
Samakovlis, C.,
Kimbrell, D. A.,
and Hultmark, D.
(1992)
Eur. J. Biochem.
204,
395-399[Medline]
[Order article via Infotrieve]
|
| 38.
|
Dimarcq, J.-L.,
Hoffmann, D.,
Meister, M.,
Bulet, P.,
Lanot, R.,
Reichhart, J.-M.,
and Hoffmann, J. A.
(1994)
Eur. J. Biochem.
221,
201-209[Medline]
[Order article via Infotrieve]
|
| 39.
|
Charlet, M.,
Lagueux, M.,
Reichhart, J.-M.,
Hoffmann, D.,
Braun, A.,
and Meister, M.
(1996)
Eur. J. Biochem.
241,
699-706[Medline]
[Order article via Infotrieve]
|
| 40.
|
Kobayashi, A.,
Hirai, H.,
Kubo, T.,
Ueno, K.,
Nakanishi, Y.,
and Natori, S.
(1989)
Biochim. Biophys. Acta
1009,
244-250[Medline]
[Order article via Infotrieve]
|
| 41.
|
Kanai, A.,
and Natori, S.
(1989)
FEBS Lett.
258,
199-202[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|